V2-0227.xml

FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v2-0227"/>
  <meta>
    <profile value="http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"/>
  </meta>
  <text>
    <status value="additional"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p>Manufacturers of Vaccines (code=MVX)</p>

      <table class="grid">
        <tr>
          <td>
            <b>Code</b>
          </td>
          <td>
            <b>Description</b>
          </td>
          <td>
            <b>Nederlands (Dutch)</b>
          </td>
          <td>
            <b>Comment</b>
          </td>
          <td>
            <b>Version</b>
          </td>
        </tr>
        <tr>
          <td>AB
            <a name="AB"> </a>
          </td>
          <td>Abbott Laboratories</td>
          <td>Abbott Laboratories</td>
          <td>(includes Ross Products Division)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>AD
            <a name="AD"> </a>
          </td>
          <td>Adams Laboratories, Inc.</td>
          <td>Adams Laboratories, Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>ALP
            <a name="ALP"> </a>
          </td>
          <td>Alpha Therapeutic Corporation</td>
          <td>Alpha Therapeutic Corporation</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>AR
            <a name="AR"> </a>
          </td>
          <td>Armour</td>
          <td>Armour</td>
          <td>[Inactive--use AVB]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>AVB
            <a name="AVB"> </a>
          </td>
          <td>Aventis Behring L.L.C.</td>
          <td>Aventis Behring L.L.C.</td>
          <td>(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB]
               CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>AVI
            <a name="AVI"> </a>
          </td>
          <td>Aviron</td>
          <td>Aviron</td>
          <td/>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>BA
            <a name="BA"> </a>
          </td>
          <td>Baxter Healthcare Corporation</td>
          <td>Baxter Healthcare Corporation</td>
          <td>[Inactive--use BAH]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>BAH
            <a name="BAH"> </a>
          </td>
          <td>Baxter Healthcare Corporation</td>
          <td>Baxter Healthcare Corporation</td>
          <td>(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>BAY
            <a name="BAY"> </a>
          </td>
          <td>Bayer Corporation</td>
          <td>Bayer Corporation</td>
          <td>(includes Miles, Inc. and Cutter Laboratories)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>BP
            <a name="BP"> </a>
          </td>
          <td>Berna Products</td>
          <td>Berna Products</td>
          <td>[Inactive--use BPC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>BPC
            <a name="BPC"> </a>
          </td>
          <td>Berna Products Corporation</td>
          <td>Berna Products Corporation</td>
          <td>(includes Swiss Serum and Vaccine Institute Berne)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>CEN
            <a name="CEN"> </a>
          </td>
          <td>Centeon L.L.C.</td>
          <td>Centeon L.L.C.</td>
          <td>[Inactive--use AVB]</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>CHI
            <a name="CHI"> </a>
          </td>
          <td>Chiron Corporation</td>
          <td>Chiron Corporation</td>
          <td>[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and
               Evans Medical Limited CDC Changes made on: July 14, 2006</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>CMP
            <a name="CMP"> </a>
          </td>
          <td>Celltech Medeva Pharmaceuticals</td>
          <td>Celltech Medeva Pharmaceuticals</td>
          <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>CNJ
            <a name="CNJ"> </a>
          </td>
          <td>Cangene Corporation</td>
          <td>Cangene Corporation</td>
          <td>CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>CON
            <a name="CON"> </a>
          </td>
          <td>Connaught</td>
          <td>Connaught</td>
          <td>[Inactive--use PMC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>DVC
            <a name="DVC"> </a>
          </td>
          <td>DynPort Vaccine Company, LLC</td>
          <td>DynPort Vaccine Company, LLC</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>EVN
            <a name="EVN"> </a>
          </td>
          <td>Evans Medical Limited</td>
          <td>Evans Medical Limited</td>
          <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>GEO
            <a name="GEO"> </a>
          </td>
          <td>GeoVax Labs, Inc.</td>
          <td>GeoVax Labs, Inc.</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>GRE
            <a name="GRE"> </a>
          </td>
          <td>Greer Laboratories, Inc.</td>
          <td>Greer Laboratories, Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>IAG
            <a name="IAG"> </a>
          </td>
          <td>Immuno International AG</td>
          <td>Immuno International AG</td>
          <td>[Inactive--use BAH]</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>IM
            <a name="IM"> </a>
          </td>
          <td>Merieux</td>
          <td>Merieux</td>
          <td>[Inactive--use PMC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>IUS
            <a name="IUS"> </a>
          </td>
          <td>Immuno-U.S., Inc.</td>
          <td>Immuno-U.S., Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>JPN
            <a name="JPN"> </a>
          </td>
          <td>The Research Foundation for Microbial Diseases of Osaka University</td>
          <td>The Research Foundation for Microbial Diseases of Osaka University</td>
          <td>(BIKEN)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>KGC
            <a name="KGC"> </a>
          </td>
          <td>Korea Green Cross Corporation</td>
          <td>Korea Green Cross Corporation</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>LED
            <a name="LED"> </a>
          </td>
          <td>Lederle</td>
          <td>Lederle</td>
          <td>[Inactive--use WAL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>MA
            <a name="MA"> </a>
          </td>
          <td>Massachusetts Public Health Biologic Laboratories</td>
          <td>Massachusetts Public Health Biologic Laboratories</td>
          <td>[Inactive--use MBL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>MBL
            <a name="MBL"> </a>
          </td>
          <td>Massachusetts Biologic Laboratories</td>
          <td>Massachusetts Biologic Laboratories</td>
          <td>(formerly Massachusetts Public Health Biologic Laboratories)</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>MED
            <a name="MED"> </a>
          </td>
          <td>MedImmune, Inc.</td>
          <td>MedImmune, Inc.</td>
          <td/>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>MIL
            <a name="MIL"> </a>
          </td>
          <td>Miles</td>
          <td>Miles</td>
          <td>[Inactive--use BAY]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>MIP
            <a name="MIP"> </a>
          </td>
          <td>Bioport Corporation</td>
          <td>Bioport Corporation</td>
          <td>(formerly Michigan Biologic Products Institute)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>MSD
            <a name="MSD"> </a>
          </td>
          <td>Merck &amp; Co., Inc.</td>
          <td>Merck &amp; Co., Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>NAB
            <a name="NAB"> </a>
          </td>
          <td>NABI</td>
          <td>NABI</td>
          <td>(formerly North American Biologicals, Inc.)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>NAV
            <a name="NAV"> </a>
          </td>
          <td>North American Vaccine, Inc.</td>
          <td>North American Vaccine, Inc.</td>
          <td>[Inactive--use BAH]</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>NOV
            <a name="NOV"> </a>
          </td>
          <td>Novartis Pharmaceutical Corporation</td>
          <td>Novartis Pharmaceutical Corporation</td>
          <td>(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited,
               Ciba-Geigy Limited and Sandoz Limited)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>NVX
            <a name="NVX"> </a>
          </td>
          <td>Novavax, Inc.</td>
          <td>Novavax, Inc.</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>NYB
            <a name="NYB"> </a>
          </td>
          <td>New York Blood Center</td>
          <td>New York Blood Center</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>ORT
            <a name="ORT"> </a>
          </td>
          <td>Ortho-Clinical Diagnostics</td>
          <td>Ortho-Clinical Diagnostics</td>
          <td>(formerly Ortho Diagnostic Systems, Inc.)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>OTC
            <a name="OTC"> </a>
          </td>
          <td>Organon Teknika Corporation</td>
          <td>Organon Teknika Corporation</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>OTH
            <a name="OTH"> </a>
          </td>
          <td>Other manufacturer</td>
          <td>Andere fabrikant</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>PD
            <a name="PD"> </a>
          </td>
          <td>Parkedale Pharmaceuticals</td>
          <td>Parkedale Pharmaceuticals</td>
          <td>(formerly Parke-Davis)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>PMC
            <a name="PMC"> </a>
          </td>
          <td>sanofi pasteur</td>
          <td>sanofi pasteur</td>
          <td>(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories
               and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>PRX
            <a name="PRX"> </a>
          </td>
          <td>Praxis Biologics</td>
          <td>Praxis Biologics</td>
          <td>[Inactive--use WAL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>PWJ
            <a name="PWJ"> </a>
          </td>
          <td>PowderJect Pharmaceuticals</td>
          <td>PowderJect Pharmaceuticals</td>
          <td>(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC
               Changes made on: July 14, 2006</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>SCL
            <a name="SCL"> </a>
          </td>
          <td>Sclavo, Inc.</td>
          <td>Sclavo, Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>SI
            <a name="SI"> </a>
          </td>
          <td>Swiss Serum and Vaccine Inst.</td>
          <td>Swiss Serum and Vaccine Inst.</td>
          <td>[Inactive--use BPC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>SKB
            <a name="SKB"> </a>
          </td>
          <td>GlaxoSmithKline</td>
          <td>GlaxoSmithKline</td>
          <td>(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>SOL
            <a name="SOL"> </a>
          </td>
          <td>Solvay Pharmaceuticals</td>
          <td>Solvay, Pharmaceuticals</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>TAL
            <a name="TAL"> </a>
          </td>
          <td>Talecris Biotherapeutics</td>
          <td>Talecris Biotherapeutics</td>
          <td>(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>UNK
            <a name="UNK"> </a>
          </td>
          <td>Unknown manufacturer</td>
          <td>Unknown manufacturer</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>USA
            <a name="USA"> </a>
          </td>
          <td>United States Army Medical Research and Material Command</td>
          <td>United States Army Medical Research and Material Command</td>
          <td/>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>VXG
            <a name="VXG"> </a>
          </td>
          <td>VaxGen</td>
          <td>VaxGen</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>WA
            <a name="WA"> </a>
          </td>
          <td>Wyeth-Ayerst</td>
          <td>Wyeth-Ayerst</td>
          <td>[Inactive--use WAL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>WAL
            <a name="WAL"> </a>
          </td>
          <td>Wyeth-Ayerst</td>
          <td>Wyeth-Ayerst</td>
          <td>(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories,
               and Praxis Biologics)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>ZLB
            <a name="ZLB"> </a>
          </td>
          <td>ZLB Behring</td>
          <td>ZLB Behring</td>
          <td>(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb.
               28, 2006</td>
          <td>added v2.6</td>
        </tr>
      </table>

    </div>
  </text>
  <url value="http://hl7.org/fhir/ValueSet/v2-0227"/>
  <version value="2.8.2"/>
  <name value="v2 Manufacturers of Vaccines (code=MVX)"/>
  <status value="active"/>
  <experimental value="true"/>
  <publisher value="HL7, Inc"/>
  <contact>
    <telecom>
      <system value="other"/>
      <value value="http://hl7.org"/>
    </telecom>
  </contact>
  <description value="FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines
     (code=MVX))"/>
  <codeSystem>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-oid">
      <valueUri value="urn:oid:2.16.840.1.133883.18.127"/>
    </extension>
    <system value="http://hl7.org/fhir/v2/0227"/>
    <caseSensitive value="false"/>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Ross Products Division)"/>
      </extension>
      <code value="AB"/>
      <display value="Abbott Laboratories"/>
      <designation>
        <language value="nl"/>
        <value value="Abbott Laboratories"/>
      </designation>
    </concept>
    <concept>
      <code value="AD"/>
      <display value="Adams Laboratories, Inc."/>
      <designation>
        <language value="nl"/>
        <value value="Adams Laboratories, Inc."/>
      </designation>
    </concept>
    <concept>
      <code value="ALP"/>
      <display value="Alpha Therapeutic Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Alpha Therapeutic Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use AVB]"/>
      </extension>
      <code value="AR"/>
      <display value="Armour"/>
      <designation>
        <language value="nl"/>
        <value value="Armour"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB]
           CDC Changes made on: Feb. 28, 2006"/>
      </extension>
      <code value="AVB"/>
      <display value="Aventis Behring L.L.C."/>
      <designation>
        <language value="nl"/>
        <value value="Aventis Behring L.L.C."/>
      </designation>
    </concept>
    <concept>
      <code value="AVI"/>
      <display value="Aviron"/>
      <designation>
        <language value="nl"/>
        <value value="Aviron"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use BAH]"/>
      </extension>
      <code value="BA"/>
      <display value="Baxter Healthcare Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Baxter Healthcare Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)"/>
      </extension>
      <code value="BAH"/>
      <display value="Baxter Healthcare Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Baxter Healthcare Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Miles, Inc. and Cutter Laboratories)"/>
      </extension>
      <code value="BAY"/>
      <display value="Bayer Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Bayer Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use BPC]"/>
      </extension>
      <code value="BP"/>
      <display value="Berna Products"/>
      <designation>
        <language value="nl"/>
        <value value="Berna Products"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Swiss Serum and Vaccine Institute Berne)"/>
      </extension>
      <code value="BPC"/>
      <display value="Berna Products Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Berna Products Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use AVB]"/>
      </extension>
      <code value="CEN"/>
      <display value="Centeon L.L.C."/>
      <designation>
        <language value="nl"/>
        <value value="Centeon L.L.C."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and
           Evans Medical Limited CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="CHI"/>
      <display value="Chiron Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Chiron Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use NOV] CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="CMP"/>
      <display value="Celltech Medeva Pharmaceuticals"/>
      <designation>
        <language value="nl"/>
        <value value="Celltech Medeva Pharmaceuticals"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="CDC Changes made on: Feb. 28, 2006"/>
      </extension>
      <code value="CNJ"/>
      <display value="Cangene Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Cangene Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use PMC]"/>
      </extension>
      <code value="CON"/>
      <display value="Connaught"/>
      <designation>
        <language value="nl"/>
        <value value="Connaught"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="DVC"/>
      <display value="DynPort Vaccine Company, LLC"/>
      <designation>
        <language value="nl"/>
        <value value="DynPort Vaccine Company, LLC"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use NOV] CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="EVN"/>
      <display value="Evans Medical Limited"/>
      <designation>
        <language value="nl"/>
        <value value="Evans Medical Limited"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="GEO"/>
      <display value="GeoVax Labs, Inc."/>
      <designation>
        <language value="nl"/>
        <value value="GeoVax Labs, Inc."/>
      </designation>
    </concept>
    <concept>
      <code value="GRE"/>
      <display value="Greer Laboratories, Inc."/>
      <designation>
        <language value="nl"/>
        <value value="Greer Laboratories, Inc."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use BAH]"/>
      </extension>
      <code value="IAG"/>
      <display value="Immuno International AG"/>
      <designation>
        <language value="nl"/>
        <value value="Immuno International AG"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use PMC]"/>
      </extension>
      <code value="IM"/>
      <display value="Merieux"/>
      <designation>
        <language value="nl"/>
        <value value="Merieux"/>
      </designation>
    </concept>
    <concept>
      <code value="IUS"/>
      <display value="Immuno-U.S., Inc."/>
      <designation>
        <language value="nl"/>
        <value value="Immuno-U.S., Inc."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(BIKEN)"/>
      </extension>
      <code value="JPN"/>
      <display value="The Research Foundation for Microbial Diseases of Osaka University"/>
      <designation>
        <language value="nl"/>
        <value value="The Research Foundation for Microbial Diseases of Osaka University"/>
      </designation>
    </concept>
    <concept>
      <code value="KGC"/>
      <display value="Korea Green Cross Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Korea Green Cross Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use WAL]"/>
      </extension>
      <code value="LED"/>
      <display value="Lederle"/>
      <designation>
        <language value="nl"/>
        <value value="Lederle"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use MBL]"/>
      </extension>
      <code value="MA"/>
      <display value="Massachusetts Public Health Biologic Laboratories"/>
      <designation>
        <language value="nl"/>
        <value value="Massachusetts Public Health Biologic Laboratories"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly Massachusetts Public Health Biologic Laboratories)"/>
      </extension>
      <code value="MBL"/>
      <display value="Massachusetts Biologic Laboratories"/>
      <designation>
        <language value="nl"/>
        <value value="Massachusetts Biologic Laboratories"/>
      </designation>
    </concept>
    <concept>
      <code value="MED"/>
      <display value="MedImmune, Inc."/>
      <designation>
        <language value="nl"/>
        <value value="MedImmune, Inc."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use BAY]"/>
      </extension>
      <code value="MIL"/>
      <display value="Miles"/>
      <designation>
        <language value="nl"/>
        <value value="Miles"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly Michigan Biologic Products Institute)"/>
      </extension>
      <code value="MIP"/>
      <display value="Bioport Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Bioport Corporation"/>
      </designation>
    </concept>
    <concept>
      <code value="MSD"/>
      <display value="Merck &amp; Co., Inc."/>
      <designation>
        <language value="nl"/>
        <value value="Merck &amp; Co., Inc."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly North American Biologicals, Inc.)"/>
      </extension>
      <code value="NAB"/>
      <display value="NABI"/>
      <designation>
        <language value="nl"/>
        <value value="NABI"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use BAH]"/>
      </extension>
      <code value="NAV"/>
      <display value="North American Vaccine, Inc."/>
      <designation>
        <language value="nl"/>
        <value value="North American Vaccine, Inc."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited,
           Ciba-Geigy Limited and Sandoz Limited)"/>
      </extension>
      <code value="NOV"/>
      <display value="Novartis Pharmaceutical Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Novartis Pharmaceutical Corporation"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="NVX"/>
      <display value="Novavax, Inc."/>
      <designation>
        <language value="nl"/>
        <value value="Novavax, Inc."/>
      </designation>
    </concept>
    <concept>
      <code value="NYB"/>
      <display value="New York Blood Center"/>
      <designation>
        <language value="nl"/>
        <value value="New York Blood Center"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly Ortho Diagnostic Systems, Inc.)"/>
      </extension>
      <code value="ORT"/>
      <display value="Ortho-Clinical Diagnostics"/>
      <designation>
        <language value="nl"/>
        <value value="Ortho-Clinical Diagnostics"/>
      </designation>
    </concept>
    <concept>
      <code value="OTC"/>
      <display value="Organon Teknika Corporation"/>
      <designation>
        <language value="nl"/>
        <value value="Organon Teknika Corporation"/>
      </designation>
    </concept>
    <concept>
      <code value="OTH"/>
      <display value="Other manufacturer"/>
      <designation>
        <language value="nl"/>
        <value value="Andere fabrikant"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly Parke-Davis)"/>
      </extension>
      <code value="PD"/>
      <display value="Parkedale Pharmaceuticals"/>
      <designation>
        <language value="nl"/>
        <value value="Parkedale Pharmaceuticals"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories
           and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006"/>
      </extension>
      <code value="PMC"/>
      <display value="sanofi pasteur"/>
      <designation>
        <language value="nl"/>
        <value value="sanofi pasteur"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use WAL]"/>
      </extension>
      <code value="PRX"/>
      <display value="Praxis Biologics"/>
      <designation>
        <language value="nl"/>
        <value value="Praxis Biologics"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC
           Changes made on: July 14, 2006"/>
      </extension>
      <code value="PWJ"/>
      <display value="PowderJect Pharmaceuticals"/>
      <designation>
        <language value="nl"/>
        <value value="PowderJect Pharmaceuticals"/>
      </designation>
    </concept>
    <concept>
      <code value="SCL"/>
      <display value="Sclavo, Inc."/>
      <designation>
        <language value="nl"/>
        <value value="Sclavo, Inc."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use BPC]"/>
      </extension>
      <code value="SI"/>
      <display value="Swiss Serum and Vaccine Inst."/>
      <designation>
        <language value="nl"/>
        <value value="Swiss Serum and Vaccine Inst."/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)"/>
      </extension>
      <code value="SKB"/>
      <display value="GlaxoSmithKline"/>
      <designation>
        <language value="nl"/>
        <value value="GlaxoSmithKline"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="SOL"/>
      <display value="Solvay Pharmaceuticals"/>
      <designation>
        <language value="nl"/>
        <value value="Solvay, Pharmaceuticals"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006"/>
      </extension>
      <code value="TAL"/>
      <display value="Talecris Biotherapeutics"/>
      <designation>
        <language value="nl"/>
        <value value="Talecris Biotherapeutics"/>
      </designation>
    </concept>
    <concept>
      <code value="UNK"/>
      <display value="Unknown manufacturer"/>
      <designation>
        <language value="nl"/>
        <value value="Unknown manufacturer"/>
      </designation>
    </concept>
    <concept>
      <code value="USA"/>
      <display value="United States Army Medical Research and Material Command"/>
      <designation>
        <language value="nl"/>
        <value value="United States Army Medical Research and Material Command"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="CDC Changes made on: July 14, 2006"/>
      </extension>
      <code value="VXG"/>
      <display value="VaxGen"/>
      <designation>
        <language value="nl"/>
        <value value="VaxGen"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="[Inactive--use WAL]"/>
      </extension>
      <code value="WA"/>
      <display value="Wyeth-Ayerst"/>
      <designation>
        <language value="nl"/>
        <value value="Wyeth-Ayerst"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories,
           and Praxis Biologics)"/>
      </extension>
      <code value="WAL"/>
      <display value="Wyeth-Ayerst"/>
      <designation>
        <language value="nl"/>
        <value value="Wyeth-Ayerst"/>
      </designation>
    </concept>
    <concept>
      <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
        <valueString value="(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb.
           28, 2006"/>
      </extension>
      <code value="ZLB"/>
      <display value="ZLB Behring"/>
      <designation>
        <language value="nl"/>
        <value value="ZLB Behring"/>
      </designation>
    </concept>
  </codeSystem>
</ValueSet>